2020 Form 10-K Financial Statement

#000143774921007832 Filed on March 31, 2021

View on sec.gov

Income Statement

Concept 2020 2019 Q4 2019
Revenue $16.92M $5.550M $19.65M
YoY Change -13.88% 17.58% -19.26%
Cost Of Revenue $14.04M $4.250M $16.85M
YoY Change -16.69% -2.52% -12.04%
Gross Profit $2.882M $1.290M $2.797M
YoY Change 3.07% 258.33% -45.99%
Gross Profit Margin 17.04% 23.24% 14.23%
Selling, General & Admin $6.734M $1.780M $7.184M
YoY Change -6.26% -17.21% -26.89%
% of Gross Profit 233.64% 137.98% 256.88%
Research & Development $372.6K $140.0K $597.5K
YoY Change -37.63% 0.0% -1.51%
% of Gross Profit 12.93% 10.85% 21.36%
Depreciation & Amortization $1.390M $240.0K $1.040M
YoY Change 33.65% -25.0% -8.77%
% of Gross Profit 48.22% 18.6% 37.19%
Operating Expenses $10.71M $1.920M $7.781M
YoY Change 37.59% -16.16% -25.41%
Operating Profit -$7.824M -$630.0K -$4.985M
YoY Change 56.96% -67.36% -5.13%
Interest Expense $444.3K -$90.00K $482.8K
YoY Change -7.98% 200.0% 4.28%
% of Operating Profit
Other Income/Expense, Net $603.3K $200.0K $411.2K
YoY Change 46.71%
Pretax Income -$7.602M -$510.0K -$4.914M
YoY Change 54.71% -74.11% -11.58%
Income Tax -$1.527M $2.110M $1.414M
% Of Pretax Income
Net Earnings -$6.075M -$2.620M -$6.328M
YoY Change -3.99% 35.75% 21.66%
Net Earnings / Revenue -35.9% -47.21% -32.21%
Basic Earnings Per Share -$0.91 -$0.96
Diluted Earnings Per Share -$0.91 -$397.0K -$0.96
COMMON SHARES
Basic Shares Outstanding 6.640M 6.565M 6.562M
Diluted Shares Outstanding 6.640M 6.562M

Balance Sheet

Concept 2020 2019 Q4 2019
SHORT-TERM ASSETS
Cash & Short-Term Investments $7.700M $8.660M $8.660M
YoY Change -11.09% -24.3% -24.3%
Cash & Equivalents $7.700M $8.664M $8.660M
Short-Term Investments
Other Short-Term Assets $710.0K $733.3K $730.0K
YoY Change -2.74% 1.4% 1.39%
Inventory $1.120M $1.710M $1.710M
Prepaid Expenses
Receivables $1.540M $2.546M $3.060M
Other Receivables $720.0K $0.00 $0.00
Total Short-Term Assets $11.79M $14.17M $14.17M
YoY Change -16.8% -27.16% -27.15%
LONG-TERM ASSETS
Property, Plant & Equipment $28.84M $32.10M $32.10M
YoY Change -10.16% 5.59% 5.59%
Goodwill
YoY Change
Intangibles $441.2K
YoY Change -10.97%
Long-Term Investments
YoY Change
Other Assets $10.00K $13.75K $10.00K
YoY Change 0.0% -78.71% -99.33%
Total Long-Term Assets $29.15M $32.56M $32.55M
YoY Change -10.45% 0.52% 0.49%
TOTAL ASSETS
Total Short-Term Assets $11.79M $14.17M $14.17M
Total Long-Term Assets $29.15M $32.56M $32.55M
Total Assets $40.94M $46.72M $46.72M
YoY Change -12.37% -9.86% -9.88%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $820.0K $535.4K $540.0K
YoY Change 51.85% -24.93% -23.94%
Accrued Expenses $1.410M $1.903M $1.900M
YoY Change -25.79% 26.58% 26.67%
Deferred Revenue $2.275M
YoY Change 324.07%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $690.0K $670.0K $670.0K
YoY Change 2.99% -21.87% -22.09%
Total Short-Term Liabilities $3.700M $5.388M $5.390M
YoY Change -31.35% 32.37% 32.43%
LONG-TERM LIABILITIES
Long-Term Debt $13.11M $11.38M $11.38M
YoY Change 15.2% -5.6% -5.56%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $13.11M $11.38M $11.38M
YoY Change 15.2% -5.6% -5.56%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.700M $5.388M $5.390M
Total Long-Term Liabilities $13.11M $11.38M $11.38M
Total Liabilities $16.81M $16.77M $16.77M
YoY Change 0.24% 3.99% 4.03%
SHAREHOLDERS EQUITY
Retained Earnings $3.172M
YoY Change -66.61%
Common Stock $26.79M
YoY Change 2.18%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $24.13M $29.96M $29.96M
YoY Change
Total Liabilities & Shareholders Equity $40.94M $46.72M $46.72M
YoY Change -12.37% -9.86% -9.88%

Cashflow Statement

Concept 2020 2019 Q4 2019
OPERATING ACTIVITIES
Net Income -$6.075M -$2.620M -$6.328M
YoY Change -3.99% 35.75% 21.66%
Depreciation, Depletion And Amortization $1.390M $240.0K $1.040M
YoY Change 33.65% -25.0% -8.77%
Cash From Operating Activities -$1.133M $2.660M $570.7K
YoY Change -298.48% -220.36% 11.95%
INVESTING ACTIVITIES
Capital Expenditures $1.577M -$570.0K $2.688M
YoY Change -41.33% 103.57% 5.93%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$1.577M -$570.0K -$2.688M
YoY Change -41.33% 103.57% 5.93%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $671.0K $657.6K
YoY Change 2.03% -11.58%
Cash From Financing Activities $1.745M -170.0K -657.6K
YoY Change -365.36% -34.62% -11.58%
NET CHANGE
Cash From Operating Activities -$1.133M 2.660M 570.7K
Cash From Investing Activities -$1.577M -570.0K -2.688M
Cash From Financing Activities $1.745M -170.0K -657.6K
Net Change In Cash -$964.9K 1.920M -2.775M
YoY Change -65.23% -169.82% 0.13%
FREE CASH FLOW
Cash From Operating Activities -$1.133M $2.660M $570.7K
Capital Expenditures $1.577M -$570.0K $2.688M
Free Cash Flow -$2.710M $3.230M -$2.118M
YoY Change 27.98% -267.36% 4.42%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q4 cvv Billings To Date
BillingsToDate
6212229
CY2019Q4 cvv Billings To Date
BillingsToDate
10645800
CY2020 cvv Capitalization Of Rightofuse Asset
CapitalizationOfRightofuseAsset
CY2019 cvv Capitalization Of Rightofuse Asset
CapitalizationOfRightofuseAsset
84354
CY2020Q4 cvv Contract Liability In Excess Of Contract Assets
ContractLiabilityInExcessOfContractAssets
292376
CY2019Q4 cvv Contract Liability In Excess Of Contract Assets
ContractLiabilityInExcessOfContractAssets
1762284
CY2020 cvv Contract With Customer Cumulative Catchup Adjustment To Revenue Change In Estimate Of Transaction Price And Input Costs
ContractWithCustomerCumulativeCatchupAdjustmentToRevenueChangeInEstimateOfTransactionPriceAndInputCosts
2100000
CY2020Q4 cvv Costs And Estimated Earnings On Uncompleted Contracts
CostsAndEstimatedEarningsOnUncompletedContracts
6551867
CY2019Q4 cvv Costs And Estimated Earnings On Uncompleted Contracts
CostsAndEstimatedEarningsOnUncompletedContracts
10313098
CY2020Q4 cvv Costs Incurred On Uncompleted Contracts
CostsIncurredOnUncompletedContracts
4464471
CY2019Q4 cvv Costs Incurred On Uncompleted Contracts
CostsIncurredOnUncompletedContracts
6943066
CY2020Q4 cvv Deferred Revenues Related To Contracts
DeferredRevenuesRelatedToContracts
632014
CY2019Q4 cvv Deferred Revenues Related To Contracts
DeferredRevenuesRelatedToContracts
1429582
CY2020Q4 cvv Deferred Tax Assets Interest Expense Carryforwards
DeferredTaxAssetsInterestExpenseCarryforwards
223768
CY2019Q4 cvv Deferred Tax Assets Interest Expense Carryforwards
DeferredTaxAssetsInterestExpenseCarryforwards
144340
CY2020 cvv Effective Income Tax Reconciliation Operating Loss Carryforward
EffectiveIncomeTaxReconciliationOperatingLossCarryforward
-1527355
CY2019 cvv Effective Income Tax Reconciliation Operating Loss Carryforward
EffectiveIncomeTaxReconciliationOperatingLossCarryforward
CY2020Q4 cvv Estimated Earnings
EstimatedEarnings
2087396
CY2019Q4 cvv Estimated Earnings
EstimatedEarnings
3370032
CY2020Q4 cvv Longterm Debt Including Acquisition Related Contingent Payment Current Maturities
LongtermDebtIncludingAcquisitionRelatedContingentPaymentCurrentMaturities
-690667
CY2019Q4 cvv Longterm Debt Including Acquisition Related Contingent Payment Current Maturities
LongtermDebtIncludingAcquisitionRelatedContingentPaymentCurrentMaturities
-674593
CY2020Q4 cvv Longterm Debt Including Acquisition Related Contingent Payment Excluding Current Maturities
LongtermDebtIncludingAcquisitionRelatedContingentPaymentExcludingCurrentMaturities
13106057
CY2019Q4 cvv Longterm Debt Including Acquisition Related Contingent Payment Excluding Current Maturities
LongtermDebtIncludingAcquisitionRelatedContingentPaymentExcludingCurrentMaturities
11377126
CY2020Q4 cvv Longterm Debt Including Acquisition Related Contingent Payment Total
LongtermDebtIncludingAcquisitionRelatedContingentPaymentTotal
13796724
CY2019Q4 cvv Longterm Debt Including Acquisition Related Contingent Payment Total
LongtermDebtIncludingAcquisitionRelatedContingentPaymentTotal
12051719
CY2020Q4 cvv Net Cost In Excess Of Billings
NetCostInExcessOfBillings
339638
CY2019Q4 cvv Net Cost In Excess Of Billings
NetCostInExcessOfBillings
-332702
CY2020 cvv Nonoperating Income Expense Including Interest Expense
NonoperatingIncomeExpenseIncludingInterestExpense
221650
CY2019 cvv Nonoperating Income Expense Including Interest Expense
NonoperatingIncomeExpenseIncludingInterestExpense
70965
CY2020Q4 cvv Number Of Wholly Owned Subsidiaries
NumberOfWhollyOwnedSubsidiaries
5
CY2020Q4 cvv Property Plant And Equipment Excluding Construction In Progress Net
PropertyPlantAndEquipmentExcludingConstructionInProgressNet
28843563
CY2019Q4 cvv Property Plant And Equipment Excluding Construction In Progress Net
PropertyPlantAndEquipmentExcludingConstructionInProgressNet
32102335
CY2020 cvv Recovery Of Contingent Earnout
RecoveryOfContingentEarnout
CY2019 cvv Recovery Of Contingent Earnout
RecoveryOfContingentEarnout
-200000
CY2020Q4 cvv Working Capital Deficit
WorkingCapitalDeficit
8100000
CY2020 dei Entity Shell Company
EntityShellCompany
false
CY2020 dei Entity Small Business
EntitySmallBusiness
true
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
817933
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
535394
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1047728
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2545537
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1409039
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1902858
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
9227566
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
7951396
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
26961684
CY2020 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2020 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2020 dei Security12b Title
Security12bTitle
Common Stock, Par Value $0.01
CY2020 dei Trading Symbol
TradingSymbol
cvv
CY2020 us-gaap Adjustment For Amortization
AdjustmentForAmortization
124550
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
26719554
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
8664253
CY2019 us-gaap Adjustment For Amortization
AdjustmentForAmortization
120488
CY2020 us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
4942204
CY2019 us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
6898372
CY2020 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
255000
CY2019 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
572000
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
164000
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
24000
CY2020 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
124550
CY2019 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
120488
CY2020Q4 us-gaap Asset Impairment Charges
AssetImpairmentCharges
3600000
CY2020 us-gaap Asset Impairment Charges
AssetImpairmentCharges
3599322
CY2019 us-gaap Asset Impairment Charges
AssetImpairmentCharges
CY2020Q4 us-gaap Assets
Assets
40935925
CY2019Q4 us-gaap Assets
Assets
46723052
CY2020Q4 us-gaap Assets Current
AssetsCurrent
11789957
CY2019Q4 us-gaap Assets Current
AssetsCurrent
14165792
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7699335
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8664253
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
11439361
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
7699335
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-964918
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2775108
CY2020Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
1000000
CY2019Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
2100000
CY2020Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
5822000
CY2019Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
5198000
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6678698
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6623793
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6678698
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6623793
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
66786
CY2019Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
7107
CY2020Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
66237
CY2020 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><div style="display: inline; text-decoration: underline;">Concentration of Credit Risk</div></div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</div> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash, cash equivalents, and accounts receivable. The Company places its cash equivalents with financial institutions and invests its excess cash primarily in treasury bills, certificates of deposit or money market instruments. The Company has established guidelines relative to credit ratings and maturities that seek to maintain stability and liquidity.</div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</div> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company sells products and services to various companies across several industries in the ordinary course of business. The Company routinely assesses the financial strength of its customers and maintains allowances for anticipated losses based upon historical experience.</div></div></div></div></div></div>
CY2020Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
494281
CY2019Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
512952
CY2019Q1 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
1400000
CY2020Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
494281
CY2019Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
512952
CY2020Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
786657
CY2019Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
2275236
CY2019Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
500000
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
786657
CY2019Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2275236
CY2020 us-gaap Cost Of Revenue
CostOfRevenue
14037813
CY2019 us-gaap Cost Of Revenue
CostOfRevenue
16850077
CY2020 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-1528305
CY2019 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
CY2020 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-1527355
CY2019 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-11506
CY2020 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
950
CY2019 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
-11506
CY2020 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
CY2019 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
1425414
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
CY2019 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1425414
CY2020 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
CY2019 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
CY2020Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
3937609
CY2019Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
2939900
CY2020Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
6969
CY2019Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
925912
CY2019Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
1798315
CY2020Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
12248
CY2019Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
52232
CY2020Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
1719598
CY2019Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
588096
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Compensated Absences
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences
89626
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Compensated Absences
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences
142230
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
211363
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
202287
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
35442
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
5293
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Impairment Losses
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses
712683
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Impairment Losses
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
3381133
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
2497414
CY2020Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
556476
CY2019Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
442486
CY2019 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
0
CY2020 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
0
CY2020 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1389145
CY2019 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1042829
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.91
CY2019 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.96
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.91
CY2019 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.96
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2019 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2020Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
12000
CY2020 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
599196
CY2019Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
488639
CY2020Q4 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
127946
CY2020Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
108344
CY2020Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
10658
CY2020Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
10658
CY2020Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
14199
CY2020Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
16852
CY2020Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
887853
CY2019Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
929816
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
288657
CY2020 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6153925
CY2019 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6285496
CY2020 us-gaap Gross Profit
GrossProfit
2882406
CY2019 us-gaap Gross Profit
GrossProfit
2796575
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-7602307
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4913750
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1527355
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1413908
CY2019 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
76448
CY2020 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-36832
CY2019 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-11506
CY2020 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
64266
CY2019 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
174416
CY2020 us-gaap Income Taxes Paid
IncomeTaxesPaid
3040
CY2019 us-gaap Income Taxes Paid
IncomeTaxesPaid
2800
CY2020Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
715599
CY2019Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
CY2020 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
282539
CY2019 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-177801
CY2020Q1 us-gaap Income Tax Receivable
IncomeTaxReceivable
1500000
CY2020Q4 us-gaap Income Tax Receivable
IncomeTaxReceivable
700000
CY2020 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
883796
CY2019 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
2497414
CY2020 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
70492
CY2019 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
57856
CY2020 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-1596485
CY2019 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-1031888
CY2020 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
743295
CY2020 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1357765
CY2019 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1519683
CY2020 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-493819
CY2019 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
315195
CY2020 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
-18671
CY2019 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
-844846
CY2020 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-1488579
CY2019 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
1278813
CY2020 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
715599
CY2019 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
CY2020 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-585874
CY2019 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-152160
CY2020 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-24162
CY2019 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
CY2020 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
CY2019 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-125056
CY2020 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
CY2019 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
CY2019Q4 us-gaap Inventory Net
InventoryNet
1709713
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
288657
CY2019Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
441177
CY2020 us-gaap Interest Expense
InterestExpense
444337
CY2019 us-gaap Interest Expense
InterestExpense
482844
CY2020 us-gaap Interest Paid Net
InterestPaidNet
445109
CY2019 us-gaap Interest Paid Net
InterestPaidNet
365254
CY2020Q4 us-gaap Inventory Net
InventoryNet
1123839
CY2020Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
928221
CY2019Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
1281250
CY2020Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
195618
CY2019Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
428463
CY2020 us-gaap Investment Income Interest
InvestmentIncomeInterest
62667
CY2019 us-gaap Investment Income Interest
InvestmentIncomeInterest
142579
CY2020Q4 us-gaap Liabilities
Liabilities
16810353
CY2019Q4 us-gaap Liabilities
Liabilities
16765207
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
40935925
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
46723052
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3704296
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5388081
CY2020Q4 us-gaap Long Term Debt
LongTermDebt
13796724
CY2020Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
690667
CY2020Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
13106057
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
13106057
CY2019Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
11377126
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1745005
CY2019 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2688231
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-657591
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1577175
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2688231
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1132748
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
570714
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-6074952
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-6327658
CY2020Q4 us-gaap Notes And Loans Payable Current
NotesAndLoansPayableCurrent
690667
CY2019Q4 us-gaap Notes And Loans Payable Current
NotesAndLoansPayableCurrent
674593
CY2020 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
3
CY2020 us-gaap Operating Expenses
OperatingExpenses
10706363
CY2019 us-gaap Operating Expenses
OperatingExpenses
7781290
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-7823957
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
-4984715
CY2020Q4 us-gaap Other Assets Current
OtherAssetsCurrent
709175
CY2019Q4 us-gaap Other Assets Current
OtherAssetsCurrent
733337
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
13748
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
13748
CY2020 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
603320
CY2019 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
411230
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1577175
CY2020 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><div style="display: inline; text-decoration: underline;">Reclassification</div></div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</div> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Certain reclassifications have been made to prior year amounts to conform with the current year presentation.</div></div></div></div></div></div>
CY2020 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
2415970
CY2019 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
38071129
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
40053731
CY2019 us-gaap Selling Expense
SellingExpense
898338
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
242679
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
572177
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
28843563
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
32102335
CY2020 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
140044
CY2019 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
CY2020 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
670965
CY2019 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
657591
CY2020 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
372648
CY2019 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
597456
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2902898
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
3172054
CY2020 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
16920219
CY2019 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
19646652
CY2020 us-gaap Selling Expense
SellingExpense
580468
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
377000
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
307930
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
417000
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
432930
CY2019 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2020 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2019 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
572177
CY2020 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
242679
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
24125572
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
29957845
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
35713326
CY2020 us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><div style="display: inline; text-decoration: underline;">Use of Estimates</div></div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</div> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</div> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company's significant estimates are the accounting for certain items such as revenues on long-term contracts recognized on the input method, depreciation and amortization, valuation of inventories at the lower of cost or net realizable value; allowance for doubtful accounts receivable; valuation allowances for deferred tax assets, impairment considerations of long-lived assets and valuation of stock-based compensation.</div></div></div></div></div></div>
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6640272
CY2019 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6562141
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6640272
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6562141

Files In Submission

Name View Source Status
0001437749-21-007832-index-headers.html Edgar Link pending
0001437749-21-007832-index.html Edgar Link pending
0001437749-21-007832.txt Edgar Link pending
0001437749-21-007832-xbrl.zip Edgar Link pending
a01.jpg Edgar Link pending
a02.jpg Edgar Link pending
a03.jpg Edgar Link pending
a04.jpg Edgar Link pending
a05.jpg Edgar Link pending
a06.jpg Edgar Link pending
a07.jpg Edgar Link pending
a08.jpg Edgar Link pending
a09.jpg Edgar Link pending
a10.jpg Edgar Link pending
a11.jpg Edgar Link pending
a12.jpg Edgar Link pending
a13.jpg Edgar Link pending
a14.jpg Edgar Link pending
a15.jpg Edgar Link pending
a16.jpg Edgar Link pending
a17.jpg Edgar Link pending
a18.jpg Edgar Link pending
a19.jpg Edgar Link pending
a20.jpg Edgar Link pending
a21.jpg Edgar Link pending
a22.jpg Edgar Link pending
a23.jpg Edgar Link pending
a24.jpg Edgar Link pending
cvv-20201231.xml Edgar Link completed
cvv-20201231.xsd Edgar Link pending
cvv-20201231_cal.xml Edgar Link unprocessable
cvv-20201231_def.xml Edgar Link unprocessable
cvv-20201231_lab.xml Edgar Link unprocessable
cvv-20201231_pre.xml Edgar Link unprocessable
cvv20201231_10k.htm Edgar Link pending
ex_237573.htm Edgar Link pending
ex_237575.htm Edgar Link pending
ex_237576.htm Edgar Link pending
ex_237577.htm Edgar Link pending
ex_237578.htm Edgar Link pending
ex_237647.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending